Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kellyann Niotis"'
Autor:
Jie Xu, Fei Wang, Chengxi Zang, Hao Zhang, Kellyann Niotis, Ava L. Liberman, Cynthia M. Stonnington, Makoto Ishii, Prakash Adekkanattu, Yuan Luo, Chengsheng Mao, Luke V. Rasmussen, Zhenxing Xu, Pascal Brandt, Jennifer A. Pacheco, Yifan Peng, Guoqian Jiang, Richard Isaacson, Jyotishman Pathak
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract The objective of this study was to investigate the potential association between the use of four frequently prescribed drug classes, namely antihypertensive drugs, statins, selective serotonin reuptake inhibitors, and proton-pump inhibitors,
Externí odkaz:
https://doaj.org/article/21a424124b6640af930c71fb694142ef
Autor:
Steven Jett, Niharika Malviya, Eva Schelbaum, Grace Jang, Eva Jahan, Katherine Clancy, Hollie Hristov, Silky Pahlajani, Kellyann Niotis, Susan Loeb-Zeitlin, Yelena Havryliuk, Richard Isaacson, Roberta Diaz Brinton, Lisa Mosconi
Publikováno v:
Frontiers in Aging Neuroscience, Vol 14 (2022)
After advanced age, female sex is the major risk factor for late-onset Alzheimer’s disease (AD), the most common cause of dementia affecting over 24 million people worldwide. The prevalence of AD is higher in women than in men, with postmenopausal
Externí odkaz:
https://doaj.org/article/6ed51b8a2c0d4d41836b3733fd3af049
Publikováno v:
Seminars in Neurology. 42:525-548
Over 55 million people globally are living with dementia and, by 2050, this number is projected to increase to 131 million. This poses immeasurable challenges for patients and their families and a significant threat to domestic and global economies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89bdf78f18805ee5641c0f1fcd5d3caf
https://doi.org/10.1055/s-0042-1759580
https://doi.org/10.1055/s-0042-1759580
Publikováno v:
Neurology. 99:10-18
Therapies that prevent the occurrence of Parkinson disease (PD) (primary prevention) or mitigate the progression of symptoms in those with early disease (secondary prevention) are a critical unmet need in disease management. Despite great promise, PD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f72949df8c69b520aff3c4165c25cd4
https://doi.org/10.1212/wnl.0000000000200812
https://doi.org/10.1212/wnl.0000000000200812
Feasibility of a wearable biosensor device to characterize exercise and sleep in neurology residents
Autor:
Matthew E. Fink, Marialaura Simonetto, Xian Wu, Peter Yan, Kellyann Niotis, Jessica P Lakis, Adam P. Buckholz, Ingrid Estrada Ariza, Nivita Sharma, Richard S. Isaacson, Nabeel Saif
Publikováno v:
Expert review of medical devices. 18(11)
Background : Research suggests optimizing sleep, exercise and work-life balance may improve resident physician burnout. Wearable biosensors may allow residents to detect and correct poor sleep and exercise habits before burnout develops. Our objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::864e523862f3be5909f9c8a0b44668eb
https://pubmed.ncbi.nlm.nih.gov/34632903
https://pubmed.ncbi.nlm.nih.gov/34632903
Autor:
Lisa Mosconi, Samuel P. Dickson, Hollie Hristov, Matthew E. Fink, Aneela Rahman, George Sadek, Juan C. Meléndez, Kellyann Niotis, Suzanne Hendrix, Robert Krikorian, Christine Greer, Mu Ji Hwang, Pei-lin Lu, Joseph Safdieh, Richard S. Isaacson, Josefina Meléndez-Cabrero, Olivia Scheyer, Matthew W. Schelke, Sonia Bellara, Katherine Hackett, Paige Lee, Madhav Thambisetty, Emily Caesar, Peter Attia, Cara Berkowitz, Monica Mureb, Nabeel Saif, Randy Cohen
Publikováno v:
Alzheimer's & Dementia. 15:1588-1602
INTRODUCTION: Multi-domain intervention for Alzheimer’s disease (AD) risk reduction is an emerging therapeutic paradigm. METHODS: Patients were prescribed individually-tailored interventions (education/pharmacologic/non-pharmacologic) and rated on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd27fc1f3d485253129ffd84b3743e16
https://doi.org/10.1016/j.jalz.2019.08.198
https://doi.org/10.1016/j.jalz.2019.08.198
Autor:
George Sadek, Kellyann Niotis, Aneela Rahman, Robert Krikorian, Olivia Scheyer, P. Yan, Richard S. Isaacson, Nabeel Saif, Sonia Bellara, Hollie Hristov, M. Berkowitz
Publikováno v:
J Prev Alzheimers Dis
Background: Alzheimer’s disease (AD) is the most common and most costly chronic neurodegenerative disease globally. AD develops over an extended period prior to cognitive symptoms, leaving a “window of opportunity” for targeted risk-reduction i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f26e9fdb1419eba38cf0a1cede03cf88
https://doi.org/10.14283/jpad.2019.39
https://doi.org/10.14283/jpad.2019.39
Autor:
Richard S. Isaacson, George Sadek, Kellyann Niotis, Yasmin Amini, Moises Dominguez, Hollie Hristov, Newman Knowlton, Mark McInnis, Paige Lee, Olivia Scheyer, John F. Hodes, Michael Woodbury, Emily Caesar, Nabeel Saif
Publikováno v:
Neurology
ObjectiveAlzheimer disease (AD) risk factors are present throughout the lifespan. This randomized controlled trial evaluated the effectiveness of various online education strategies concerning AD risk reduction and brain health in younger populations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37e4d31ce926bbf532c3815e02ae5f14
https://pubmed.ncbi.nlm.nih.gov/32665410
https://pubmed.ncbi.nlm.nih.gov/32665410
Autor:
Pei-lin Lu, Matthew W. Schelke, Kellyann Niotis, Joseph Safdieh, Robert Krikorian, Richard S. Isaacson, Mu Ji Hwang, Josefina Meléndez-Cabrero, George Sadek, Samuel P. Dickson, Hollie Hristov, Aneela Rahman, Matthew E. Fink, Juan C. Meléndez, Lisa Mosconi, Suzanne Hendrix, Christine Greer, Sonia Bellara, Nabeel Saif, Randy Cohen, Katherine Hackett, Peter Attia, Emily Caesar, Paige Lee, Cara Berkowitz, Olivia Scheyer, Madhav Thambisetty
Publikováno v:
Alzheimer's & Dementia. 15:P1246-P1247
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0df76dc219742e3a9dd9b42ee6ac2cb
https://doi.org/10.1016/j.jalz.2019.06.4773
https://doi.org/10.1016/j.jalz.2019.06.4773
Autor:
Matthew D. Hellmann, Kellyann Niotis, Mariza Daras, Margaret K. Callahan, Caroline Chaul-Barbosa
BACKGROUNDSurvival benefit with immune checkpoints inhibitors in patients with metastatic NSCLC and Melanoma has been demonstrated. However, the published results do not describe the incidence of brain metastasis as a site of recurrence in these pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5126e52cfdb24ca80341e4fcdb154b0
https://europepmc.org/articles/PMC5692893/
https://europepmc.org/articles/PMC5692893/
